|
[1]IELUZZI D,COVOLO L,DONATO F,et al.Progression to cirrhosis,hepatocellular carcinoma and liver-related mortality in chronic hepatitis B patients in Italy[J].Dig Liver Dis,2014,46(5):427-432.
|
|
[2]BALMASOVA IP,YUSHCHUK ND,MYNBAEV OA,et al.Immunopathogenesis of chronic hepatitis B[J].World J Gastroenterol,2014,20(39):14156-14171.
|
|
[3]UTSUNOMIYA T,SSHIMADA M,KUDO M,et al.A comparison of the surgical outcomes among patients with HBV-positive,HCV-positive,and non-B non-C hepatocellular carcinoma:a nationwide study of 11,950 patients[J].Ann Surg,2015,261(3):513-520.
|
|
[4]Mc MAHON BJ.The natural history of chronic hepatitis B virus infection[J].Hepatology,2009,49(Suppl 5):s45-s55.
|
|
[5]HUANG Y,ZHU ZY,DU Z.Research progress on Th17/Treg involved in hepatic diseases[J].Int J Lab Med,2011,32(16):1856-1858.(in Chinese)黄勇,朱争艳,杜智.Th17/Treg在肝脏疾病中的作用研究进展[J].国际检验医学杂志,2011,32(16):1856-1858.
|
|
[6]HE JN,ZHAO SS.Research advances in association between regulatory T cells and hepatitis B virus infection[J].J Clin Hepatol,2016,32(2):361-365.(in Chinese)何俊楠,赵守松.调节性T淋巴细胞与HBV感染慢性化的关系[J].临床肝胆病杂志,2016,32(2):361-365.
|
|
[7]ALATRAKCHI N,KOZIEL M.Regulatory T cells and viral liver disease[J].J Viral Hepat,2009,16(4):223-229.
|
|
[8]CMARA NO,SEBILLE F,LECHLER RI.Human CD4+CD25+regulatory cells have marked and sustained effects on CD8+T cell activation[J].Eur J Immunol,2003,33(12):3473-3483.
|
|
[9]WANG W,SHAO S,JIAO Z,et al.The Th17/Treg imbalance and cytokine environment in peripheral blood of patients with rheumatoid arthritis[J].Rheumatol Int,2012,32(4):887-893.
|
|
[10]YE Y,XIE X,YU J,et al.Involvement of Th17 and Th1 effector responses in patients with hepatitis B[J].J Clin Immunol,2010,30(4):546-555.
|
|
[11]YAN J,LIU XL,XIAO G,et al.Prevalence and clinical relevance of T-helper cells,Th17 and Th1,in hepatitis B virus-related hepatocellular carcinoma[J].PLo S One,2014,9(5):e96080.
|
|
[12]ANNUNZIATO F,COSMI L,SANTARLASCI V,et al.Phenotypic and functional features of human Th17 cells[J].J Exp Med,2007,204(8):1849-1861.
|
|
[13]OUYANG W,KOLLS JK,ZHENG Y.The biological functions of T helper 17 cell effector cytokines in inflammation[J].Immunity,2008,28(4):454-467.
|
|
[14]HAMMERICH L,HEYMANN F,TACKE F.Role of IL-17 and Th17 cells in liver diseases[J].Clin Dev Immunol,2011,2011:345803.
|
|
[15]IVANOV II,Mc KENZIE BS,ZHOU L,et al.The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+T helper cells[J].Cell,2006,126(6):1121-1133.
|
|
[16]LI J,QIU SJ,SHE WM,et al.Significance of the balance between regulatory T(Treg)and T helper 17(Th17)cells during hepatitis B virus related liver fibrosis[J].PLo S One,2012,7(6):e39307.
|
|
[17]STOOP JN,van der MOLEN RG,BAAN CC,et al.Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection[J].Hepatology,2005,41(4):771-778.
|
|
[18]PENG G,LI S,WU W,et al.Circulating CD4+CD25+regulatory T cells correlate with chronic hepatitis B infection[J].Immunology,2008,123(1):57-65.
|
|
[19]XU D,FU J,JIN L,et al.Circulating and liver resident CD4+CD25+regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B[J].J Immunol,2006,177(1):739-747.
|
|
[20]WANG Q,ZHENG Y,HUANG Z,et al.Activated IL-23/IL-17 pathway closely correlates with increased Foxp3 expression in livers of chronic hepatitis B patients[J].BMC Immunol,2011,12(1):25.
|
|
[21]LI CD,CHEN XL,TIAN PF,et al.Correlation analysis of percentages of T lymphocyte subsets and CD4+CD25+regulatory T cells and HBV DNA level in peripheral blood of chronic hepatitis B patients[J].J Clin Hepatol,2015,31(4):541-545.(in Chinese)李彩东,陈锡莲,田鹏飞,等.慢性乙型肝炎患者外周血中T淋巴细胞亚群和CD4+CD25+调节性T淋巴细胞的表达水平与HBV DNA定量的相关分析[J].临床肝胆病杂志,2015,31(4):541-545.
|
|
[22]WANG FS.Clinical immune characterization of hepatitis B virus infection and implications for immune intervention:progress and challenges[J].Hepatol Res,2007,37(Suppl 3):s339-s346.
|
|
[23]FRANZESE O,KENNEDY PT,GEHRING AJ,et al.Modulation of the CD8+-T-cell response by CD4+CD25+regulatory T cells in patients with hepatitis B virus infection[J].J Virol,2005,79(6):3322-3328.
|
|
[24]STROSS L,GNTHER J,GASTEIGER G,et al.Foxp3+regulatory T cells protect the liver from immune damage and compromise virus control during acute experimental hepatitis B virus infection in mice[J].Hepatology,2012,56(3):873-883.
|
|
[25]CHEN Y,FANG J,CHEN X,et al.Effects of the Treg/Th17 cell balance and their associated cytokines in patients with hepatitis B infection[J].Exp Ther Med,2015,9(2):573-578.
|
|
[26]WEI HX,CHUANG YH,LI B,et al.CD4+CD25+Foxp3+regulatory T cells protect against T cell-mediated fulminant hepatitis in a TGFβ-dependent manner in mice[J].J Immunol,2008,181(10):7221-7229.
|
|
[27]ERHARDT A,BIBURGER M,PAPADOPOULOS T,et al.IL-10,regulatory T cells,and Kupffer cells mediate tolerance in concanavalin A-induced liver injury in mice[J].Hepatology,2007,45(2):475-485.
|
|
[28]WANG F,JING X,LI G,et al.Foxp3+regulatory T cells are associated with the natural history of chronic hepatitis B and poor prognosis of hepatocellular carcinoma[J].Liver Int,2012,32(4):644-655.
|
|
[29]ZHANG H,MEI M,FEI R,et al.Regulatory T cells in chronic hepatitis B patients affect the immunopathogenesis of hepatocellular carcinoma by suppressing the anti-tumour immune responses[J].J Viral Hepat,2010,17(Suppl 1):34-43.
|
|
[30]HUANG Y,WANG F,WANG Y,et al.Intrahepatic interleukin-17+T cells and Foxp3+regulatory T cells cooperate to promote development and affect the prognosis of hepatocellular carcinoma[J].J Gastroenterol Hepatol,2014,29(4):851-859.
|
|
[31]HUANG Y,WANG FM,WANG T,et al.Tumor-infiltrating Foxp3+Tregs and CD8+T cells affect the prognosis of hepatocellular carcinoma patients[J].Digestion,2012,86(4):329-337.
|
|
[32]SUN H,ZHANG J,ZHANG H,et al.Increased Th17 cells contribute to disease progression in patients with HBV‐associated liver cirrhosis[J].J Viral Hepat,2012,19(6):396-403.
|
|
[33]HUANG JF,XU T,PAN XN,et al.Measurement of peripheral blood Treg,Tr1,and Th17 cells in patients with chronic hepatitis B and its clinical significance[J].J Clin Hepatol,2015,31(4):551-555.(in Chinese)黄进发,徐涛,潘兴南,等.慢性乙型肝炎患者外周血中调节性T淋巴细胞,Ⅰ型调节性T淋巴细胞和辅助性T淋巴细胞17的表达特点及临床意义[J].临床肝胆病杂志,2015,31(4):551-555.
|
|
[34]WANG L,CHEN S,XU K.IL-17 expression is correlated with hepatitis B-related liver diseases and fibrosis[J].Int J Mol Med,2011,27(3):385-392.
|
|
[35]TAN Z,QIAN X,JIANG R,et al.IL-17A plays a critical role in the pathogenesis of liver fibrosis through hepatic stellate cell activation[J].J Immunol,2013,191(4):1835-1844.
|
|
[36]ZHAO J,ZHANG Z,LUAN Y,et al.Pathological functions of interleukin-22 in chronic liver inflammation and fibrosis with hepatitis B virus infection by promoting T helper 17 cell recruitment[J].Hepatology,2014,59(4):1331-1342.
|
|
[37]ZHANG F,YAO S,YUAN J,et al.Elevated IL-6 receptor expression on CD4+T cells contributes to the increased Th17 responses in patients with chronic hepatitis B[J].Virol J,2011,8:270.
|
|
[38]NUMASAKI M,FUKUSHI JI,ONO M,et al.Interleukin-17 promotes angiogenesis and tumor growth[J].Blood,2003,101(7):2620-2627.
|
|
[39]GRETEN TF,ZHAO F,GAMREKELASHVILI J,et al.Human Th17 cells in patients with cancer:friends or foe?[J].Oncoimmunology,2012,1(8):1438-1439.
|
|
[40]ZHANG X,ZHENG X,HE F,et al.Expression of interleukin-17A in primary liver cancer and its clinical significance[J].Chin J Hepatobiliary Surg,2013,19(2):143-146.(in Chinese)张玄,郑翔,何凡,等.原发性肝癌中白细胞介素-17A的表达及其临床意义[J].中华肝胆外科杂志,2013,19(2):143-146.
|
|
[41]ZHAO F,HOECHST B,GAMREKELASHVILI J,et al.Human CCR4+CCR6+Th17 cells suppress autologous CD8+T cell responses[J].J Immunol,2012,188(12):6055-6062.
|
|
[42]LIAO Y,WANG B,HUANG ZL,et al.Increased circulating Th17cells after transarterial chemoembolization correlate with improved survival in stage III hepatocellular carcinoma:a prospective study[J].PLo S One,2013,8(4):e60444.
|
|
[43]ZHANG GL,XIE DY,LIN BL,et al.Imbalance of interleukin-17-producing CD4 T cells/regulatory T cells axis occurs in remission stage of patients with hepatitis B virus-related acute-onchronic liver failure[J].J Gastroenterol Hepatol,2013,28(3):513-521.
|
|
[44]LIANG XS,LI CZ,ZHOU Y,et al.Changes in circulating Foxp3+regulatory T cells and interleukin-17-producing T helper cells during HBV-related acute-on-chronic liver failure[J].World J Gastroenterol,2014,20(26):8558.
|
|
[45]DONG X,GONG Y,ZENG H,et al.Imbalance between circulating CD4+regulatory T and conventional T lymphocytes in patients with HBV-related acute-on-chronic liver failure[J].Liver Int,2013,33(10):1517-1526.
|
|
[46]YANG B,WANG Y,ZHAO C,et al.Increased Th17 cells and interleukin-17 contribute to immune activation and disease aggravation in patients with chronic hepatitis B virus infection[J].Immunol Lett,2013,149(1-2):41-49.
|
|
[47]NIU Y,LIU H,YIN D,et al.The balance between intrahepatic IL-17+T cells and Foxp3+regulatory T cells plays an important role in HBV-related end-stage liver disease[J].BMC Immunol,2011,12:47.
|
|
[48]KIM HY,JHUN JY,CHO ML,et al.Interleukin-6 upregulates Th17 response via m TOR/STAT3 pathway in acute-on-chronic hepatitis B liver failure[J].J Gastroenterol,2014,49(8):1264-1273.
|
|
[49]YU X,GUO R,MING D,et al.Ratios of regulatory T cells/Thelper 17 cells and transforming growth factor-β1/interleukin-17to be associated with the development of hepatitis B virus-associated liver cirrhosis[J].J Gastroenterol Hepatol,2014,29(5):1065-1072.
|
DownLoad: